Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

One off PSA prostate screening for men does not save lives

Prof Richard Martin - University of Bristol, Bristol, UK
One off PSA prostate screening for men does not save lives ( Prof Richard Martin - University of Bristol, Bristol, UK )
29 Mar 2018

The Integrative Cancer Epidemiology Programme

Prof Richard Martin - University of Bristol, Bristol, UK
The Integrative Cancer Epidemiology Programme ( Prof Richard Martin - University of Bristol, Bristol, UK )
29 Mar 2018

Editor’s Choice for March 2018

Prof Gordon McVie - Founding Editor, ecancer
Editor’s Choice for March 2018 ( Prof Gordon McVie - Founding Editor, ecancer )
29 Mar 2018

Coping with extreme fatigue after cancer

Dora Vonk - Tired of Cancer, Utrecht, Netherlands
Coping with extreme fatigue after cancer ( Dora Vonk - Tired of Cancer, Utrecht, Netherlands )
20 Mar 2018

Management of marker negative stage II testicular cancer

Dr Christian Kollmannsberger - University of British Columbia, Vancouver, Canada
Management of marker negative stage II testicular cancer ( Dr Christian Kollmannsberger - University of British Columbia, Vancouver, Canada )
16 Mar 2018

Editor's Choice for February 2018

Prof Gordon McVie - Founding Editor, ecancer
Editor's Choice for February 2018 ( Prof Gordon McVie - Founding Editor, ecancer )
26 Feb 2018

Sustainability of cancer care

Dr Paolo Foggi - The Italian Medicines Agency (AIFA), Italy
Sustainability of cancer care ( Dr Paolo Foggi - The Italian Medicines Agency (AIFA), Italy )
21 Feb 2018

Durvalumab plus tremelimumab or durvalumab monotherapy in metastatic urothelial carcinoma

Dr Guru Sonpavde - Dana-Farber Cancer Institute, Boston, USA
Durvalumab plus tremelimumab or durvalumab monotherapy in metastatic urothelial carcinoma ( Dr Guru Sonpavde - Dana-Farber Cancer Institute, Boston, USA )
9 Feb 2018

Genetic mutations: New therapeutic avenues in metastatic prostate cancer

Dr Joaquin Mateo - Vall d'Hebron Institute of Oncology, Barcelona, Spain
Genetic mutations: New therapeutic avenues in metastatic prostate cancer ( Dr Joaquin Mateo - Vall d'Hebron Institute of Oncology, Barcelona, Spain )
9 Feb 2018

Serum miRNA to predict post-chemotherapy viable disease in testicular non-seminomatous germ cell tumour patients

Dr Ricardo Leão - University of Toronto, Toronto, Canada
Serum miRNA to predict post-chemotherapy viable disease in testicular non-seminomatous germ cell tumour patients ( Dr Ricardo Leão - University of Toronto, Toronto, Canada )
8 Feb 2018

Radium-223 for bone predominant metastatic castration resistant prostate cancer

Dr Andrew Armstrong - Duke University School of Medicine, Durham, USA
Radium-223 for bone predominant metastatic castration resistant prostate cancer ( Dr Andrew Armstrong - Duke University School of Medicine, Durham, USA )
8 Feb 2018

FALCON: Impact of 18F-fluciclovine PET/CT on management of biochemically recurrent prostate cancer

Dr Eugene Teoh - University of Oxford, Oxford, UK
FALCON: Impact of 18F-fluciclovine PET/CT on management of biochemically recurrent prostate cancer ( Dr Eugene Teoh - University of Oxford, Oxford, UK )
8 Feb 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation